NatureCell Co

NatureCell Co Equity

The The Equity of NatureCell Co (007390.KQ) as of Oct 25, 2026 is 63.03 B KRW. In the previous year, The Equity was 64.62 B KRW — a change of -2.47% (lower).

Equity

63.03 BKRW

YoY

-2.47%

Last updated:

In 2025, NatureCell Co's equity was 63.03 B KRW, a -2.47% increase from the 64.62 B KRW equity in the previous year.

The NatureCell Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
43.13 B KRW
Jan 1, 2019
81.89 B KRW
Jan 1, 2020
62.68 B KRW
Jan 1, 2021
60.85 B KRW
Jan 1, 2022
57.16 B KRW
Jan 1, 2023
61.42 B KRW
Jan 1, 2024
64.62 B KRW
Jan 1, 2025
63.03 B KRW
The NatureCell Co Equity history
YEAREquityYoY
63.03 BKRW-2.47%
64.62 BKRW+5.22%
61.42 BKRW+7.45%
57.16 BKRW-6.06%
60.85 BKRW-2.93%
62.68 BKRW-23.45%
81.89 BKRW+89.87%
43.13 BKRW+9.24%
39.48 BKRW+16.06%
34.02 BKRW+7.36%
31.69 BKRW+130.48%
13.75 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NatureCell Co Stock analysis

What does NatureCell Co do? NatureCell Co Ltd generates revenue through three business segments. The Stem Cell Business segment develops stem cell therapeutics, manufactures stem cell culture media, sells stem cell culture cosmetics, and provides blood cell storage services. The Food Business segment produces and sells fruit beverages like tomato juice and peach juice, canned beverages such as sikhye, fruit concentrates, and health functional foods. The Hygiene Business segment manufactures and sells health hygiene products including masks, disinfectants, and wipes. These segments target consumers seeking medical solutions, healthy beverages, and personal care items. The Stem Cell Business segment serves customers interested in advanced medical treatments and skincare, while the Food Business segment caters to consumers looking for natural beverage and health food options. The Hygiene Business segment appeals to individuals prioritizing health and safety through products like masks and disinfectants. All segments focus on delivering quality products under NatureCell's brand name. NatureCell's product portfolio spans therapeutic, beverage, and hygiene categories, with each segment operating independently yet contributing to the company's overall revenue. The Stem Cell Business segment's offerings include culture media and cosmetics, the Food Business segment's products are fruit-based beverages and functional foods, and the Hygiene Business segment provides essential health care items. These diverse segments ensure a steady income stream across multiple consumer needs. NatureCell Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing NatureCell Co's Equity

NatureCell Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding NatureCell Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating NatureCell Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

NatureCell Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in NatureCell Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about NatureCell Co stock

The Equity of NatureCell Co is 63.03 B KRW in 2025.

The Equity of NatureCell Co changed from 64.62 B KRW to 63.03 B KRW, representing a -2.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity NatureCell Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's NatureCell Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — NatureCell Co

All Key Metrics — NatureCell Co